SG52949A1 - Novel retinoids - Google Patents

Novel retinoids

Info

Publication number
SG52949A1
SG52949A1 SG1997001077A SG1997001077A SG52949A1 SG 52949 A1 SG52949 A1 SG 52949A1 SG 1997001077 A SG1997001077 A SG 1997001077A SG 1997001077 A SG1997001077 A SG 1997001077A SG 52949 A1 SG52949 A1 SG 52949A1
Authority
SG
Singapore
Prior art keywords
novel retinoids
retinoids
novel
Prior art date
Application number
SG1997001077A
Other languages
English (en)
Inventor
Michael Klaus
Peter Mohr
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of SG52949A1 publication Critical patent/SG52949A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/20—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by carboxyl groups or halides, anhydrides, or (thio)esters thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/62—Unsaturated compounds containing ether groups, groups, groups, or groups containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09—Geometrical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG1997001077A 1996-04-15 1997-04-08 Novel retinoids SG52949A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96105849 1996-04-15

Publications (1)

Publication Number Publication Date
SG52949A1 true SG52949A1 (en) 1998-09-28

Family

ID=8222666

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1997001077A SG52949A1 (en) 1996-04-15 1997-04-08 Novel retinoids

Country Status (29)

Country Link
US (1) US5990329A (zh)
JP (1) JP2801589B2 (zh)
KR (1) KR100240542B1 (zh)
CN (1) CN1116270C (zh)
AR (1) AR006632A1 (zh)
AT (1) ATE187962T1 (zh)
AU (1) AU715816B2 (zh)
BR (1) BR9701790A (zh)
CA (1) CA2202228C (zh)
CO (1) CO4890844A1 (zh)
CZ (1) CZ113397A3 (zh)
DE (1) DE59700872D1 (zh)
DK (1) DK0802181T3 (zh)
ES (1) ES2141556T3 (zh)
HK (1) HK1003054A1 (zh)
HR (1) HRP970204B1 (zh)
HU (1) HU220112B (zh)
IL (1) IL120637A (zh)
MA (1) MA24142A1 (zh)
NO (1) NO308842B1 (zh)
NZ (1) NZ314525A (zh)
PE (1) PE42498A1 (zh)
PL (1) PL319477A1 (zh)
PT (1) PT802181E (zh)
SG (1) SG52949A1 (zh)
TR (1) TR199700297A2 (zh)
TW (1) TW442459B (zh)
YU (1) YU14997A (zh)
ZA (1) ZA972944B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2344653A1 (en) 1998-09-29 2000-04-06 Gamida Cell Ltd. Methods of controlling proliferation and differentiation of stem and progenitor cells
IL152904A0 (en) 2002-01-24 2003-06-24 Gamida Cell Ltd Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
WO2003062404A1 (en) 2002-01-25 2003-07-31 Gamida-Cell Ltd. Methods of expanding stem and progenitor cells and expanded cell populations obtained thereby
WO2006030442A2 (en) 2004-09-16 2006-03-23 Gamida-Cell Ltd. Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells
US8846393B2 (en) 2005-11-29 2014-09-30 Gamida-Cell Ltd. Methods of improving stem cell homing and engraftment
US20150064273A1 (en) 2012-02-13 2015-03-05 Gamida-Cell Ltd. Mesenchymal Stem Cells Conditioned Medium and Methods of Generating and Using the Same
US9175266B2 (en) 2012-07-23 2015-11-03 Gamida Cell Ltd. Enhancement of natural killer (NK) cell proliferation and activity
US9567569B2 (en) 2012-07-23 2017-02-14 Gamida Cell Ltd. Methods of culturing and expanding mesenchymal stem cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4169103A (en) * 1978-04-12 1979-09-25 Hoffmann-La Roche Inc. Nonatetraenoic acid derivatives
DE2843901A1 (de) * 1978-10-07 1980-04-24 Basf Ag Mittel, enthaltend all-e- oder 13-z-7, 8-dehydro-retinsaeure
CH658387A5 (de) * 1984-04-02 1986-11-14 Hoffmann La Roche Pharmazeutische praeparate.
CZ282548B6 (cs) * 1992-01-22 1997-08-13 F. Hoffmann-La Roche Ag Farmaceutický přípravek

Also Published As

Publication number Publication date
DE59700872D1 (de) 2000-01-27
HRP970204A2 (en) 1998-04-30
PT802181E (pt) 2000-05-31
ATE187962T1 (de) 2000-01-15
JP2801589B2 (ja) 1998-09-21
AU715816B2 (en) 2000-02-10
HRP970204B1 (en) 2000-10-31
HU9700747D0 (en) 1997-05-28
NO971711L (no) 1997-10-16
CN1116270C (zh) 2003-07-30
ES2141556T3 (es) 2000-03-16
JPH1036343A (ja) 1998-02-10
IL120637A (en) 2000-11-21
BR9701790A (pt) 1998-11-10
YU14997A (sh) 1999-09-27
MX9702697A (es) 1997-10-31
MA24142A1 (fr) 1997-12-31
HU220112B (hu) 2001-11-28
CO4890844A1 (es) 2000-02-28
AR006632A1 (es) 1999-09-08
CA2202228C (en) 2007-03-06
KR100240542B1 (ko) 2000-01-15
NZ314525A (en) 1998-02-26
HUP9700747A1 (en) 1997-12-29
US5990329A (en) 1999-11-23
CA2202228A1 (en) 1997-10-15
TR199700297A2 (xx) 1997-11-21
CN1167752A (zh) 1997-12-17
KR970069969A (ko) 1997-11-07
HUP9700747A3 (en) 1998-04-28
NO971711D0 (no) 1997-04-14
PE42498A1 (es) 1998-08-18
PL319477A1 (en) 1997-10-27
NO308842B1 (no) 2000-11-06
AU1772697A (en) 1997-10-23
IL120637A0 (en) 1997-08-14
CZ113397A3 (cs) 1998-02-18
TW442459B (en) 2001-06-23
HK1003054A1 (en) 1998-10-09
DK0802181T3 (da) 2000-04-17
ZA972944B (en) 1997-10-15

Similar Documents

Publication Publication Date Title
DE69634986D1 (en) Modulares wandlersystem
DE59704951D1 (en) Plättchenförmiges titandioxidpigment
DE69608577D1 (en) Thermostabiler schalldämmstoff
DE69702926D1 (en) Polyurethanhartschäume
DE69705420D1 (en) Polyurethanhartschäume
DE59705192D1 (en) Lcp-blends
SG60040A1 (en) Novel heterroaryl-oxazolidinones
DE59711450D1 (en) Arylalkanoylpyridazine
DE59700372D1 (en) Blockcopolymere
DE69703480D1 (en) Anionische photokatalysator
DE69621466D1 (en) Thermoplastische hydroxy-phenoxyetherpolymerverbundwerkstoffe
DE59707730D1 (en) Peripheralpumpe
DE59704086D1 (en) Twin-dualmode-filter
DE59703905D1 (en) Linearmotorgetriebene transportanlage
SG52949A1 (en) Novel retinoids
EP0895545A4 (en) A NEW PROTEIN, TRAF 6
ZA972591B (en) Substituted 1-methyl-3-benzyluracils
ZA9711235B (en) Substituted pyrazol-3-ylbenzazoles
DE59703023D1 (en) Cyclopeptidderivate
DE59702027D1 (en) Bragg-modulator
DE59711583D1 (en) Heterocyclyluracile
DE59709914D1 (en) Substituierte aromatische phosphonsäurederivate
DE59705556D1 (en) Peripheralpumpe
AU131132S (en) Handleset
DE69706982D1 (en) Wärmeisolationspaneel